Fractyl Health, Inc. announced promising preclinical data for its Rejuva Smart GLP-1 pancreatic gene therapy at the American Diabetes Association’s Scientific Sessions, revealing that a single dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback